BaseLaunch, CTI and LSZYSN present “Partnering and/or VC financing for seed stage companies ?” on April 19

Emerging companies can expedite growth through partnering and/or VC financing. We aim to address the key steps, opportunities, bottlenecks and challenges in the partnering process versus criteria for an alternative VC financing. In the first part, Helmut Kessmann will provide an overview on the partnering / licensing option and potential scenarios. Markus Goebel will then elaborate on how a major Pharma and Investment Fund will look at these companies and assets and the key criteria to evaluate such opportunities.

Come join us at this event, which will take place at the Universität Zürich Irchel, (Winterthurerstrasse 190) in Zurich, on April 19th, 2017 (18:00; door opening 17: 50). The event location is Hörsaal Y15-G-19.



Welcome & introduction to BaseLaunch, CTI, LSZYSN
Stephan Emmerth, BaseLaunch; Stefan Blarer, CTI; Daniel Gaul, LSYZN


Emerging company perspective 
Helmut Kessmann, Polyphor, T3 Pharma

Corporate VC perspective 
Markus Goebel, Novartis Venture Fund


Participation is free of charge but registration is compulsory.